130 related articles for article (PubMed ID: 4853307)
21. Growth of a methylcholanthrene-induced fibrosarcoma in mice with diabetes mellitus.
Pavelić K
Eur J Cancer (1965); 1980 Feb; 16(2):279-84. PubMed ID: 6989613
[No Abstract] [Full Text] [Related]
22. Effect of regional lymphadenectomy on development of concomitant immunity.
Soloway MS; Pendergrast WJ; Myers GH
Surg Forum; 1972; 23(0):101-2. PubMed ID: 4671039
[No Abstract] [Full Text] [Related]
23. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
Simmons RL; Rios A; Lundgren G; Ray PK; McKhann CF; Haywood GR
Surgery; 1971 Jul; 70(1):38-46. PubMed ID: 5092115
[No Abstract] [Full Text] [Related]
24. [Morphologic behavior of a fibrosarcoma following transplantation into various organs].
Krüger G; Ritter K
Osterr Z Erforsch Bekampf Krebskr; 1970; 25(3):143-51. PubMed ID: 5287030
[No Abstract] [Full Text] [Related]
25. Changes in spleen morphology and lymphoid cell activity during tumor progression.
Yamagishi H; Pellis NR; Macek C; Kahan BD
Eur J Cancer (1965); 1980 Nov; 16(11):1417-26. PubMed ID: 7227418
[No Abstract] [Full Text] [Related]
26. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
Milas L; Hunter N; Mason K; Withers HR
Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
[No Abstract] [Full Text] [Related]
27. Regression of established methylcholanthrene tumors by intratumor injections of Vbrio cholerae neuraminidase.
Simmons RL; Rios A; Ray PK
J Surg Oncol; 1972; 4(4):298-305. PubMed ID: 5083567
[No Abstract] [Full Text] [Related]
28. Immunogenic strength of sarcomas induced by methylcholanthrene in millipore filter diffusion chambers.
Parmiani G; Carbone G; Lembo R
Cancer Res; 1973 Apr; 33(4):750-4. PubMed ID: 4696474
[No Abstract] [Full Text] [Related]
29. The effect of curative cryosurgery on the tumor-specific immune response of C57 mice.
Faraci RP; Bagley DH; Marrone JA; Beazley RM
Cryobiology; 1975 Apr; 12(2):175-9. PubMed ID: 1126183
[No Abstract] [Full Text] [Related]
30. Tumor growth in the guinea pig: alpha globulin changes associated with lymphocyte suppression.
Lilley DP; Burger DR; Vetto RM
J Natl Cancer Inst; 1974 Sep; 53(3):701-9. PubMed ID: 4138027
[No Abstract] [Full Text] [Related]
31. Detection of private and common tumor-associated antigens in murine sarcomas induced by different chemical carcinogens.
Fritze D; Kern DH; Humme JA; Drogemuller CR; Pilch YH
Int J Cancer; 1976 Jan; 17(1):138-47. PubMed ID: 1248898
[TBL] [Abstract][Full Text] [Related]
32. [Changes of antigenicity and growth rate of murine sarcomas induced by a chemical carcinogen (author's transl)].
Pierotti M; Ménard S
Tumori; 1974 Jan; 60(1):33-44. PubMed ID: 4841997
[No Abstract] [Full Text] [Related]
33. The fate of methylcholanthrene tumor cells in bone: analysis of immune factors in host resistance.
McLaughlin AP; Kessler WO; Clark PL; Gittes RF
J Surg Res; 1973 Mar; 14(3):186-92. PubMed ID: 4702159
[No Abstract] [Full Text] [Related]
34. [Current topics on tumor immunology].
Tachibana T
Gan No Rinsho; 1983 Oct; 29(13):1492-8. PubMed ID: 6608013
[TBL] [Abstract][Full Text] [Related]
35. In vitro demonstration of tumor-specific common antigens and embryonal antigens in murine fibrosarcomas induced by 7,12-dimethylbenz(a)anthracene.
Ménard S; Colnaghi MI; Della Porta G
Cancer Res; 1973 Mar; 33(3):478-81. PubMed ID: 4689897
[No Abstract] [Full Text] [Related]
36. A quantitative system for assay of malignant transformation by chemical carcinogens using a clone derived from BALB-3T3.
Kakunaga T
Int J Cancer; 1973 Sep; 12(2):463-73. PubMed ID: 4792350
[No Abstract] [Full Text] [Related]
37. Ascites tumors in CBA mice. Characterization of two new tumors, a carcinoma and a sarcoma in solid and ascites form, with regard to cell surface properties and transplantability.
Ryd W; Hagmar B
J Cancer Res Clin Oncol; 1979 Jun; 94(2):185-99. PubMed ID: 468905
[TBL] [Abstract][Full Text] [Related]
38. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens.
Brannen GE; Adams JS; Santos GW
J Natl Cancer Inst; 1974 Jul; 53(1):165-75. PubMed ID: 4600504
[No Abstract] [Full Text] [Related]
39. Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells.
Röllinghoff M; Warner NL
Proc Soc Exp Biol Med; 1973 Dec; 144(3):813-8. PubMed ID: 4543620
[No Abstract] [Full Text] [Related]
40. Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
Simmons RL; Rios A
Ann Surg; 1972 Aug; 176(2):188-94. PubMed ID: 4562008
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
